Rapid improvement in refractory acrodermatitis continua of Hallopeau with spesolimab injection
We present the case of a patient with acrodermatitis continua of Hallopeau (ACH) who was resistant to traditional therapies such as acitretin, ciclosporin and methotrexate, as well as secukinumab and ustekinumab, who was successfully treated with subcutaneous spesolimab, resulting in rapid resolution of skin lesions.
Authors
- Haoxiang Xu (ORCID: https://orcid.org/0000-0002-5047-5341)
- Hao Chen (ORCID: https://orcid.org/0000-0003-0857-7405)
- Mengli Zhang (ORCID: https://orcid.org/0000-0003-4147-394X)
- Yong He
- Jingshu Xiong
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Chinese Academy of Medical Sciences Dermatology Hospital (CN)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2024-10-22
- DOI
- https://doi.org/10.1093/ced/llae443
- Citations
- 1
- Primary Topic
- Skin Diseases and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.53